TABLE 2.
Effect of homologous and heterologous antisera on YbST- and YST I-induced fluid accumulation in infant mice
| Treated preparationsa | Fluid accumulation ratio after treatment withb:
|
||||
|---|---|---|---|---|---|
| TSB/YE | Anti-YST I antiserumc | Anti-YbST antiserumd | Normal rabbit serum | Normal mouse serum | |
| YbST | 0.130 ± 0.01 | 0.129 ± 0.01 | 0.048 ± 0.02 | NDe | 0.110 ± 0.01 |
| YST I | 0.087 ± 0.02 | 0.049 ± 0.02 | 0.087 ± 0.02 | 0.082 ± 0.01 | ND |
| TSB/YE | 0.047 ± 0.01 | 0.047 ± 0.02 | 0.048 ± 0.01 | ND | 0.048 ± 0.01 |
Aliquots (600 μl) of YbST- and YST I-containing CSF were incubated (1 h; 37°C) with an equal volume of undiluted homologous and heterologous antisera, TSB/YE, and normal sera prior to assaying in infant mice.
All fluid accumulation ratios are means (minimum of six animals) ± standard deviations.
A gift from Donald Robertson, University of Idaho.
Antiserum against YbST was raised in 10 female, adult (25- to 30-g), CD-1 albino mice (Charles River Laboratories, Inc., Wilmington, Mass.) by subcutaneous administration of a water-in-oil emulsion (0.2 ml) composed of equal parts of boiled Y. bercovieri 6519 CSF (concentrated ca. 100-fold by ultrafiltration with a 3-kDa cut-off membrane) and Freund incomplete adjuvant. The mice received injections on day 0 and at weeks 5, 9, and 11 and were exsanguinated 1 week after the last injection. The sera were pooled, heat treated (56°C; 30 min), and stored at 4°C.
ND, not done.